Related Experiment Video
Updated: Jul 1, 2025

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
Shorter versus longer-course of antibiotic therapy for urinary tract infections in pediatric population: an updated
Marcus Vinicius Barbosa Moreira1, Lucas Rezende de Freitas2, Luiza Mendes Fonseca3
1Department of Medicine, Potiguar University, Av. Sen. Salgado Filho, 1610 - Lagoa Nova, Natal, Brazil. marcus.vbmoreira1@gmail.com.
Insights
Longer antibiotic courses (≥7 days) for pediatric urinary tract infections (UTIs) show lower treatment failure rates compared to shorter courses (≤5 days). Reinfection and relapse rates were similar between groups within 15 months.
Area of Science:
- Pediatric infectious diseases
- Clinical pharmacology
Background:
- Urinary tract infections (UTIs) are common bacterial infections in febrile children.
- There is no established consensus on the optimal duration of oral antibiotic therapy for pediatric UTIs.
Purpose of the Study:
- To compare the effectiveness of short-course (≤5 days) versus long-course (≥7 days) oral antibiotic therapy for pediatric UTIs.
- To assess treatment failure, reinfection, and relapse rates in children with UTIs based on antibiotic therapy duration.
Main Methods:
- A meta-analysis of randomized controlled trials (RCTs) was conducted.
- Searches were performed in PubMed, Cochrane, and Embase databases.
- Seventeen studies involving 1666 pediatric patients were analyzed using statistical methods and risk of bias assessment.
Main Results:
- Short-course antibiotic therapy was associated with significantly higher treatment failure rates (RR 1.61; p=0.006).
- No statistically significant differences were found in reinfection (RR 0.73; p=0.156) or relapse rates (RR 1.47; p=0.270) between short and long-course therapies within 15 months.
Conclusions:
- Long-course oral antibiotic therapy appears more effective in reducing treatment failure for pediatric UTIs.
- Current evidence does not support a difference in reinfection or relapse rates based on therapy duration within a 15-month period.
Abstract:
Urinary tract infections (UTI) affect between 3% to 7.5% of the febrile pediatric population each year, being one of the most common bacterial infections in pediatrics. Nevertheless, there is no consensus in the medical literature regarding the duration of per oral (p.o.) antibiotic therapy for UTI among these patients. Therefore, our meta-analysis aims to assess the most effective therapy length in this scenario. PubMed, Cochrane, and Embase were searched for randomized controlled trials (RCTs) comparing short (≤ 5 days) with long-course (≥ 7 days) per os (p.o.) antibiotic therapy for children with UTI. Statistical analysis was performed using R Studio version 4.2.1, heterogeneity was assessed with I2 statistics, and the risk of bias was evaluated using the RoB-2 tool. Risk Ratios (RR) with p < 0.05 were considered statistically significant. Seventeen studies involving 1666 pediatric patients were included. Of these, 890 patients (53.4%) were randomized to receive short-course therapy. Patients undergoing short-course therapy showed higher treatment failure rates (RR 1.61; 95% CI 1.15-2.27; p = 0.006). Furthermore, there were no statistically significant differences between groups regarding reinfection (RR 0.73; 95% CI 0.47-1.13; p = 0156) and relapse rates (RR 1.47; 95% CI 0.8-2.71; p = 0.270). Conclusion: In summary, our results suggest that long-course p.o. antibiotic therapy is associated with a lower rate of treatment failure when compared to short-course p.o. antibiotic therapy. There was no statistical difference between both courses regarding reinfection and relapse rates within 15 months. PROSPERO identifier: CRD42023456745. What is Known: • Urinary tract infections (UTIs) are common in children, affecting around 7.5% of those under 18. • The optimal duration of antibiotic treatment for pediatric UTIs has been a subject of debate. What is New: • Short-course therapy (5 or fewer days) was associated with a significantly higher failure rate when compared to long-course therapy. • There was no significant difference in reinfection and relapse rates within 15 months between short and long-course therapy.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Tonsillitis II: Management
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

